We are live on ! Find out more
COCH icon

Envoy Medical

80 hedge funds and large institutions have $319M invested in Envoy Medical in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 3

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

36% more capital invested

Capital invested by funds: $235M → $319M (+$83.9M)

20.03% more ownership

Funds ownership: 56.99%77.02% (+20%)

18% more funds holding

Funds holding: 6880 (+12)

Holders
80
Holders Change
+12
Holders Change %
+17.65%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
15
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MF
76
Magnetar Financial
Illinois
$101K
EC
77
EJF Capital
Virginia
$78K -$233K -23,859 -75%
CS
78
Clear Street
New York
$34K +$33.7K +3,456 New
UBS Group
79
UBS Group
Switzerland
$9K -$8.88K -910 -50%
TRCT
80
Tower Research Capital (TRC)
New York
$7K +$6.77K +694 New
MIM
81
Monashee Investment Management
Massachusetts
-$1.46M -149,991 Closed
OAC
82
OMERS Administration Corp
Ontario, Canada
-$679K -69,999 Closed
WAM
83
Wolverine Asset Management
Illinois
-$8K -891 Closed

COCH Hedge Fund Activity: Q4 2021 in Review

80 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2021, worth a combined $319M — up 36% from $235M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new COCH positions and 3 closed out — a net gain of 14 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Aristeia Capital, opening a new position worth an estimated $26.1M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.46M sold.

  • 80 institutional investors held Envoy Medical (COCH) as of Q4 2021, up from 68 in Q3 2021.
  • Funds reported $319M of Envoy Medical stock for Q4 2021, up 36% quarter-over-quarter.
  • 17 funds opened new Envoy Medical positions in Q4 2021 and 3 closed out, a net change of +14 holders.
  • The largest Envoy Medical buyer in Q4 2021 was Aristeia Capital, an estimated $26.1M added.
  • The largest Envoy Medical seller in Q4 2021 was Monashee Investment Management, an estimated $1.46M sold.

Based on aggregated 13F filings for Q4 2021.